International Stem Cell Corporation Announces the Signing of a Distribution Agreement with Veritas Corporation, Opening Japanese Markets for Its Lifeline Cell Technology(R) Brand of Human Cell Culture Products
OCEANSIDE, Calif.--(BUSINESS WIRE)--International Stem Cell Corporation (OTCBB: ISCO), www.internationalstemcell.com, announced today its wholly-owned subsidiary, Lifeline Cell Technology (Lifeline), www.lifelinecelltech.com, has signed a distribution agreement with Tokyo-based Veritas Corporation to distribute its human cell culture products throughout Japan.